CD33 CAR T Cells(Beijing Boren Hospital) | Interleukin Related interleukin-related.com

Product Name :
CD33 CAR T Cells(Beijing Boren Hospital)

Search keywords :
CD33

drugId :
null

Target Vo:
Myeloid cell surface antigen CD33

Target Vo Short Name :
CD33

Moa_Name:
Myeloid cell surface antigen CD33 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Beijing Gao Boren Hospital Co Ltd

Active Company_Name :
Beijing Gao Boren Hospital Co Ltd

Active Indication_Name:
Leukemia

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Mitazalimab Apoptosis
Ibalizumab medchemexpress
Integrin beta 3 Antibody: Integrin beta 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Integrin beta 3. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts